| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/20/2002 | WO2001052837A3 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
| 06/20/2002 | WO2001027154A3 Membrane translocating peptide drug delivery system |
| 06/20/2002 | WO2001022917A8 Effervescent compositions comprising nimesulide |
| 06/20/2002 | WO2000072857A9 Fibrin polymer structure |
| 06/20/2002 | US20020077620 Drug delivery system for implantable medical device |
| 06/20/2002 | US20020077589 Method and apparatus for producing an injectable foam |
| 06/20/2002 | US20020077588 Automatic liquid injection system and method |
| 06/20/2002 | US20020077485 Stable dissolution profile |
| 06/20/2002 | US20020077461 Pharmaceutical formulation |
| 06/20/2002 | US20020077437 For administering a therapeutic agent to a patient |
| 06/20/2002 | US20020077372 For cosmetic and medicinal use; stability |
| 06/20/2002 | US20020077368 Administering fluorocarbon to at least one articular region for therapy |
| 06/20/2002 | US20020077364 Thyroid hormone formulations |
| 06/20/2002 | US20020077346 For therapy of inflammatory and pain of a traumatic or pathologic origin |
| 06/20/2002 | US20020077334 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/20/2002 | US20020077328 Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain |
| 06/20/2002 | US20020077314 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 06/20/2002 | US20020077303 For therapy of human and animal tumors |
| 06/20/2002 | US20020077280 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 06/20/2002 | US20020076455 Novel preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability |
| 06/20/2002 | US20020076449 Preserved cyclodextrin-containing compositions |
| 06/20/2002 | US20020076447 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency |
| 06/20/2002 | US20020076446 Novel medicinal herbal composition for treating liver diseases and HIV |
| 06/20/2002 | US20020076445 Eukaryotic cells and method for preserving cells |
| 06/20/2002 | US20020076444 Novel method for obtaining microspheres and resulting products |
| 06/20/2002 | US20020076443 Multiple phase cross-linked compositions and uses thereof |
| 06/20/2002 | US20020076442 Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders |
| 06/20/2002 | US20020076441 A biodegradable gel matrix and a microparticle system wherein the microparticle is embedded in the biodegradable gel matrix, from which bioactive agent is released in a controlled manner |
| 06/20/2002 | US20020076440 A pliable film comprising a binder, a lubricant, a solvent for binder, a lubricant and a drug; placing pliable film within the oral cavity of the animal |
| 06/20/2002 | US20020076439 Orally administerable drug in combination with an effervescent as a penetration enhancer for influencing absorption of a drug in the gastrointestinal tract |
| 06/20/2002 | US20020076438 Spheronized beadlet containing acid labile group is selected from the group consisting of 2', 3'-dideoxyadenosine, 2', 3' dideoxycytidine, pravstatin, erythromycin, digoxin and pancreatin |
| 06/20/2002 | US20020076437 Flashmelt oral dosage formulation |
| 06/20/2002 | US20020076436 Compressed tablet formulation |
| 06/20/2002 | US20020076435 Capsule prepared from a omeprazole or its alkaline salt , an oily compound or salt, an emulsifier selected from organic fatty acid and an organic amine, a polycarbon alcohol; and an enteric coating on the outer layer of the capusle |
| 06/20/2002 | US20020076434 Liposomal retinoid therapy in hormone refractory prostate cancer |
| 06/20/2002 | US20020076433 Breath freshening comestible product and method of controlling breath malodor |
| 06/20/2002 | US20020076432 Encapsulated long chain alcohols |
| 06/20/2002 | US20020076430 Micronized compound selected from the group consisting of cellulose acetate phthalate and hydroxypropylmethylcellulose phthalate; and a water soluble cellulose compound; foaming, freezing and freeze-drying |
| 06/20/2002 | US20020076426 Use of terpene alcohol ethoxylates as solubilizers in cosmetic or pharmaceutical preparations or concentrates for food preparations |
| 06/20/2002 | US20020076421 Oral liquid mucoadhesive compositions |
| 06/20/2002 | US20020076397 Implanting in an eye of encapsulated cells which produce polypeptides that exhibit neurotrophic and/or antiangiogenic activity, such as fibroblast growth factor; encapsulation prevents immune reaction |
| 06/20/2002 | US20020076396 Intraocular transplantation of encapsulated cells |
| 06/20/2002 | US20020076394 Delivery system for gene therapy to the brain |
| 06/20/2002 | US20020076383 Administering an aerosolized mixture of lipid crystals comprised of a mixture of one or more lipids surfactants and spreading agents in powder form and propellants directly to the ear canal |
| 06/20/2002 | US20020076382 As well as drug delivery devices and dosage forms |
| 06/20/2002 | US20020076381 Novel compositions for use in embolizing blood vessels |
| 06/20/2002 | US20020074679 Method for manufacturing multi-layered, air-gapped sheet of chitosan |
| 06/20/2002 | US20020074514 Multiple ultraviolet sensitive patches on a single strip and a process for manufacturing thereof |
| 06/20/2002 | US20020073511 Method and apparatus for the formation of particles |
| 06/20/2002 | DE10145910A1 Ophtalmologische Formulierung mit verlangsamter Freisetzung und langer Verweildauer sowie Herstellungsverfahren hierfür Ophthalmic formulation with delayed release and long residence time and manufacturing method thereof |
| 06/20/2002 | DE10063378A1 Aufkleber mit Verflüssigungsmittel für natürliche Atemwegssekrete Sticker with liquefying agent for natural airway secretions |
| 06/20/2002 | DE10062712A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden New pharmaceutical compositions based on anticholinergics and corticosteroids |
| 06/20/2002 | DE10062624A1 Oral verabreichbarer Stoff mit schwammartiger Struktur Orally available substance with a sponge-like structure |
| 06/20/2002 | DE10061137A1 Pharmaceutical preparation comprising drug in matrix of fatty alcohol, triglyceride, partial glyceride and/or fatty acid ester, providing taste masking, gastric fluid resistance and/or controlled release functions |
| 06/20/2002 | DE10060852A1 Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems Absorbents and channel-containing drug impermeable cover layer or removable protective layer of a transdermal therapeutic system |
| 06/20/2002 | DE10059318A1 Kosmetische Mittel enthaltend Alk(en)ylbernsteinsäurederivate Cosmetic products containing ylbernsteinsäurederivate alk (en) |
| 06/20/2002 | CA2447900A1 Drug delivery compositions and medical devices containing block copolymer |
| 06/20/2002 | CA2445091A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | CA2431896A1 Compound |
| 06/20/2002 | CA2431852A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | CA2431322A1 Medicinal compositions having improved absorbability |
| 06/20/2002 | CA2431319A1 Pharmaceutical composition having an improved water solubility |
| 06/20/2002 | CA2431287A1 Method and apparatus for treating breakthrough pain |
| 06/20/2002 | CA2431285A1 Microparticles with an improved release profile and method for the production thereof |
| 06/20/2002 | CA2431250A1 Composition for regulating animal growth, method of manufacture and use thereof |
| 06/20/2002 | CA2431172A1 Nmda receptor antagonist pharmaceutical compositions |
| 06/20/2002 | CA2431044A1 Oral compositions and use thereof |
| 06/20/2002 | CA2427625A1 Preparation of drug particles using evaporation precipitation into aqueous solutions |
| 06/19/2002 | EP1214945A2 Method and medicament for inhibiting the expression of a defined gene |
| 06/19/2002 | EP1214944A1 Percutaneous absorption agents |
| 06/19/2002 | EP1214937A2 Terfenadine carboxylate and the treatment of dermal irritation |
| 06/19/2002 | EP1214935A2 Fusogenic liposome composition and method |
| 06/19/2002 | EP1214934A2 Agent with spongy structure for oral administration |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214892A1 A moisture and oxygen stable composition and a process for obtaining said composition |
| 06/19/2002 | EP1214886A1 Acidic oil-in-water type emulsion composition |
| 06/19/2002 | EP1214879A2 Antifungal fragrance composition |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214361A1 Temperature sensitive polymers |
| 06/19/2002 | EP1214300A2 Rate-controlled particles |
| 06/19/2002 | EP1214129A1 Process for producing fine medicinal substances |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | EP1214096A2 Taxane prodrugs |
| 06/19/2002 | EP1214095A1 Use of anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 06/19/2002 | EP1214094A1 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 06/19/2002 | EP1214093A1 Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 06/19/2002 | EP1214078A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 06/19/2002 | EP1214076A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 06/19/2002 | EP1214075A1 POLYMORPHS OF N-METHYL-N-(3- 3- 2-THIENYLCARBONYL]-PYRAZOL- 1,5-$g(a)]-PYRIMIDIN-7-YL PHENYL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 06/19/2002 | EP1214068A1 Ophthalmic fluid |
| 06/19/2002 | EP1214064A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 06/19/2002 | EP1214062A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 06/19/2002 | EP1214061A2 Use of docetaxel for treating hepatocellular carcinoma |
| 06/19/2002 | EP1214059A2 Surface modified particulate compositions of biologically active substances |
| 06/19/2002 | EP1214058A1 Method to obtain microparticles |
| 06/19/2002 | EP1214057A1 Vascular coating composition |
| 06/19/2002 | EP1214056A1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 06/19/2002 | EP1214055A2 Pharmaceutical gel containing active substances |
| 06/19/2002 | EP1214054A1 Intranasal influenza virus vaccine |
| 06/19/2002 | EP1214053A1 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one nonionic surfactant |